Streamly
Categories & TopicsEvents & BrandsExperts
LoginSign Up
Categories & TopicsEvents & BrandsExperts
LoginSign Up
Carbon MitigationResiliencyEnergyResourcesBiodiversitySocial Sustainability Tools & FrameworksStrategy
Private CapitalBankingFintechWealth & Investment ManagementInsurance
Content StrategyData & AnalyticsSocial MediaLeadership & CultureMarketing Strategy
Growth StrategyLeadership & CultureTools & MethodologyCybersecurityTelecommunications
Leadership & CultureTools & MethodologyConsumer InsightsStrategy
RenewablesHydrogenBiofuelsEnergy & Battery StorageDecarbonisationInfrastructure & Development
Digital HealthChronic DiseaseAged Care & DisabilityHospital ManagementFunding, Policy & WorkforceLegal & Ethical IssuesBiotech & PharmaHealth Infrastructure
RestaurantsIndustryMenuCulinaryRetailWorkforceOperationsConsumers
Leadership & CultureStrategyDiversity, Equity & InclusionInspiration
Future of WorkLearning & Development Employee ExperienceHR TechLeadership & CultureTalent Acquisition
RailHaulage & Freight DecarbonisationInfrastructure
SustainabilityFinanceMarketingInnovation & TechnologyData & InsightsEnergyHealthcareFoodserviceLeadershipHRTransport & InfrastructureMeetings & EventsBuildings & Real Estate

Navigating The Path of Dementia Research

Navigating The Path of Dementia Research

0:00
0%
0:00
|
0:00
https://cdn.streamly.video/Dementia_Care_9_e5cda3f818.png
PREVIEW
Dementiachronic disease
Prof Tina SoulisProf Tina SoulisFounder & Director at Alithia Life Sciences

A/Prof Tina Soulis has over 27 years of working in the healthcare (pharmaceuticals and devices), biotechnology, academic research, clinical research and management sectors in senior roles including: CEO of a Contract Research Organization, Director of a successful ASX200 company, VP of Clinical Strategy and Development with an innovative biotechnology company and now, Founder and Director of her own clinical consultancy company. A dynamic and strategic leader, Tina has an extensive network of stakeholders all over the world and experience in many therapeutic areas across all phases on development.

The Self who Decides? Precedent Autonomy, Supported Decision-making and Dementia
The Self who Decides? Precedent Autonomy, Supported Decision-making and Dementia
The increasing role of allied health in Dementia care now and in the future
The increasing role of allied health in Dementia care now and in the future
Quality Palliative Care for people with Dementia – are we there yet?
Quality Palliative Care for people with Dementia – are we there yet?
Mindful Dementia Care: Redefining the approach to dementia support programs for people with dementia and their carers
Mindful Dementia Care: Redefining the approach to dementia support programs for people with dementia and their carers
KEYNOTE | Introducing Complex Change in Hospitals - the Dementia Care in Hospitals Program (DCHP)
KEYNOTE | Introducing Complex Change in Hospitals - the Dementia Care in Hospitals Program (DCHP)
OPENING KEYNOTE | Dementia Advocates – The diversity of advocacy work…the challenges and benefits
OPENING KEYNOTE | Dementia Advocates – The diversity of advocacy work…the challenges and benefits
Show more content
Description

Join Tina Soles, Founder and Director of Lithia Life Sciences, as she emphasizes the vital role of clinical evidence in the development of innovative dementia treatments.

Discover the significant findings from recent studies utilizing monoclonal antibodies and gain valuable insights into the significance of informed consent.

Table Of Contents
The importance of clinical trials in the field of dementia research
Challenges in dementia clinical trials
Successful dementia clinical trial example
Considerations for dementia clinical trial participation
The future of clinical trial
0
Your cart